Download Files:
555 CAD – 2,320 CADPrice range: 555 CAD through 2,320 CAD
Products Details
Product Description
– Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
Web ID
– T76795
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Weyer-Czernilofsky U, et al. Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models. Mol Cancer Ther. 2020 Apr;19(4):1059-1069.
CAS Number
– 1417158-65-6
Molecular Weight
Compound Purity
– 0.95
Pathway
– PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
